Free Courses Sale ends Soon, Get It Now
GS PAPER II: Issues Relating to Development and Management of Social Sector/Services relating to Health, Education, Human Resources.
Context: The Drugs Controller General of India (DCGI) has granted permission for emergency use of anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr. Reddy’s Laboratories (DRL),Hyderabad.
Drugs Controller General of India
Functions of DCGI:
© 2024 iasgyan. All right reserved